Global Embolic Agents Market, 2021-2027

January 2022 | 82 pages | ID: GD7FED206974EN
Gen Consulting Company

Abstracts

Embolization is a minimally invasive treatment that blocks one or more blood vessels or abnormal vascular channels. According to Gen Consulting Company, the global embolic agents market size is expected to increase from USD 1,879 million in 2020 to USD 3,037 million by 2027, garnering a CAGR of 7.1% over the evaluated period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global embolic agents market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The embolic agents market is segmented on the basis of product, application, end user, and region. The embolic agents market is segmented as below:

By product:

• beads & particles
• coils
• detachable balloons
• glue
• liquid embolics
• plugs
• precipitating agents
• sclerosants
• sponge
• others

By application:

• oncology
• neurology
• urology
• cardiology
• peripheral vascular diseases
• others

By end user:

• hospitals
• cardiac centers
• ambulatory surgical centers (ASCs)
• others

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global embolic agents market. Some of the leading players profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Cook Group Incorporated, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Merit Medical Systems, Inc., Penumbra, Inc., Stryker Corporation, Terumo Corporation, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global embolic agents market.
• To classify and forecast the global embolic agents market based on product, application, end user, and region.
• To identify drivers and challenges for the global embolic agents market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global embolic agents market.
• To identify and analyze the profile of leading players operating in the global embolic agents market.

Why Choose This Report

• Gain a reliable outlook of the global embolic agents market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR EMBOLIC AGENTS BY PRODUCT

5.1 Beads & particles
  5.1.1 Market size and forecast
5.2 Coils
  5.2.1 Market size and forecast
5.3 Detachable balloons
  5.3.1 Market size and forecast
5.4 Glue
  5.4.1 Market size and forecast
5.5 Liquid embolics
  5.5.1 Market size and forecast
5.6 Plugs
  5.6.1 Market size and forecast
5.7 Precipitating agents
  5.7.1 Market size and forecast
5.8 Sclerosants
  5.8.1 Market size and forecast
5.9 Sponge
  5.9.1 Market size and forecast
5.10 Others
  5.10.1 Market size and forecast

PART 6. GLOBAL MARKET FOR EMBOLIC AGENTS BY APPLICATION

6.1 Oncology
  6.1.1 Market size and forecast
6.2 Neurology
  6.2.1 Market size and forecast
6.3 Urology
  6.3.1 Market size and forecast
6.4 Cardiology
  6.4.1 Market size and forecast
6.5 Peripheral vascular diseases
  6.5.1 Market size and forecast
6.6 Others
  6.6.1 Market size and forecast

PART 7. GLOBAL MARKET FOR EMBOLIC AGENTS BY END USER

7.1 Hospitals
  7.1.1 Market size and forecast
7.2 Cardiac centers
  7.2.1 Market size and forecast
7.3 Ambulatory surgical centers (ASCs)
  7.3.1 Market size and forecast
7.4 Others
  7.4.1 Market size and forecast

PART 8. GLOBAL MARKET FOR EMBOLIC AGENTS BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Abbott Laboratories
9.2 Boston Scientific Corporation
9.3 Cook Group Incorporated
9.4 Johnson & Johnson
9.5 Kaneka Corporation
9.6 Medtronic plc
9.7 Merit Medical Systems, Inc.
9.8 Penumbra, Inc.
9.9 Stryker Corporation
9.10 Terumo Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY